HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor.

Abstract
A 68 year-old man, initially managed with primary percutaneous coronary intervention (PCI) to the right coronary artery (RCA) for an inferior ST elevation myocardial infarction (STEMI) with residual disease requiring coronary artery bypass graft surgery (CABG), re-presented with chest pain. There were no acute ischaemic changes on ECG and his pain settled with nitrates. A day later, he developed left sided abdominal pain and hypovolaemic shock after straining in the toilet. A subsequent computed tomography (CT) scan of his abdomen revealed an omental bleed. He proceeded to emergency laparotomy, recovered well, and was discharged on aspirin and clopidogrel. Apart from dual antiplatelet therapy with aspirin and ticagrelor, and presumed raised intra-abdominal pressure, there were no other identified risk factors for increased bleeding.
AuthorsVictoria E Cheng, Anne Oppermen, Dinesh Natarajan, Deepak Haikerwal, Jeremy Pereira
JournalHeart, lung & circulation (Heart Lung Circ) Vol. 23 Issue 4 Pg. e115-7 (Apr 2014) ISSN: 1444-2892 [Electronic] Australia
PMID24480082 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2013 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Chemical References
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Clopidogrel
  • Ticagrelor
  • Adenosine
  • Ticlopidine
  • Aspirin
Topics
  • Adenosine (administration & dosage, adverse effects, analogs & derivatives)
  • Aged
  • Aspirin
  • Clopidogrel
  • Gastrointestinal Hemorrhage (chemically induced, therapy)
  • Humans
  • Male
  • Myocardial Infarction (therapy)
  • Platelet Aggregation Inhibitors (administration & dosage)
  • Purinergic P2Y Receptor Antagonists (administration & dosage, adverse effects)
  • Ticagrelor
  • Ticlopidine (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: